Skip to main content

Thermo Fisher Breaks Ground on New Facility in India to Support Local Pharmas

NEW YORK (GenomeWeb News) — Thermo Fisher Scientific has broken ground on a $17 million facility in India designed to support its biopharmaceutical customers in the country.
 
Thermo Fisher said the 100,000-square-foot facility, located in the western city of Ahmadabad, will be responsible for packaging, distributing, and managing logistics for pharmaceutical samples that will be part of drug trials around the world.
 
The company expects to open the facility in the spring of 2008 and add approximately 100 employees in the first year of operation.
 
"Large pharmaceutical companies are focusing more and more on India for their future clinical research and development programs," Thermo Fisher CEO Marijn Dekkers said in a statement.
 
"They are looking to outsource their clinical trials management to partners who know how to work within changing regional and global clinical trial regulations,” he added.

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.